(79.64% Upside) Based on 6 analysts offering 12 month price targets for Ovid Therapeutics in the last 3 months. Enjoy free access to the POWR Ratings for all stocks and ETFs on the quote pages. Learn everything you need to know about successful options trading with this three-part video course. According to analysts' consensus price target of $12.57, Ovid Therapeutics has a forecasted upside of 237.9% from its current price of $3.72. Receive a free world-class investing education from MarketBeat. The price target was set to $17.00 → $5.00. The average price target is $6.00 … All rights reserved. OVID has a higher average analyst price target than 11.86% of all US stocks. See
Teachable moments from GameStop, Deere & Company (NYSE:DE) Turns In Huge Earnings Beat, Jack In The Box Stock Is Ready To Spring Forward. Fundamental company data provided by Zacks Investment Research. Ovid Therapeutics Inc's variance in analysts' estimates is lower than 15.08% of stocks in the small market cap category. The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors. Shares of OVID stock opened at $3.43 on Friday. LADENBURG THALM/SH SH dropped their price target on Ovid Therapeutics from $21.00 to $7.00 and set a "buy" rating on the stock in a research report on Wednesday, December 2nd. Ovid … © American Consumer News, LLC dba MarketBeat® 2010-2021. Ovid Therapeutics Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock… Get the latest Ovid Therapeutics (OVID) stock price quote with real-time news, financials, charts and other important investing information. Barron's also provides information on historical stock ratings, target prices, company earnings, market … The stock has a 50 day moving average price of $2.81 and a 200 day moving average price of $4.76. Find the latest Ovid Therapeutics Inc. (OVID) stock quote, history, news and other vital information to help you with your stock trading and investing. Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com! Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Arista Gets Back to Growth, Should You Buy? Ovid Therapeutics Inc NASDAQ Updated Feb 16, 2021 8:59 PM. above. The high price target for OVID is $40.00 and the low price target for OVID is $4.00. View our full suite of financial calendars and market data tables, all for free. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 OVID has a higher upside potential (average analyst target price relative to current price) than 85.78% of all US stocks. Royal Bank of Canada is very positive to OVID and gave it a "Outperform" rating on December 02, 2020. MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. 5,920 According to . Ovid Therapeutics Stock Forecast, OVID stock price prediction. If you've got money invested in the stock market, but are confused as to what to do next...This is the can't-miss interview of 2021... MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. What happens next will shock you…". Considering analysts have assigned the stock a … Based on analysts offering 12 month price targets for OVID in the last 3 months. Ovid Therapeutics Inc. (OVID) stock forecast and price target. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. investment rating Join. The upside potential (average analyst target price relative to current price) of OVID is higher than 86.01% of all US stocks. Export data to Excel for your own analysis. View real-time stock prices and stock quotes for a full financial overview. Ovid Therapeutics Inc. analyst estimates, including OVID earnings per share estimates and analyst recommendations. $6.00. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. You can opt out at any time. Palladium just blew past the critical $2,000 per ounce level, signaling an unprecedented wealth-building opportunity in select palladium stocks. Further, Ovid Therapeutics Inc. (OVID) has a beta value of 1.83, and an average true range (ATR) of 0.3. We have 9 different ratings for every stock to help you
Learn more. Just enter your email address below. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. The chart below shows how a company's share price and consensus price target have changed over time. 3 Wall Street analysts that have issued a 1 year OVID price target, the average OVID price target is $6.33, with the highest OVID stock price forecast at $8.00 and the lowest OVID stock price … View today's stock price, news and analysis for Ovid Therapeutics Inc. (OVID). In March and again in June, Ladenburg Thalmann analyst Michael Higgins gave the stock a $20 price target. Do Not Sell My Information. Man Who Predicted March 2020 Crash Says 2021 Is The Time. Ovid Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. The firm has a market capitalization of $217.58 million, a P/E ratio of -2.43 and a beta of 1.86. Try POWR Ratings for free. ----- Michael Higgins, an analyst with Ladenburg Thalmann, reiterated a buy rating on Ovid's stock … OVID 3.73 0.31 (9.06%). Their average twelve-month price target is $12.57, predicting that the stock has a possible upside of 259.18%. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . Learn about financial terms, types of investments, trading strategies and more. Please log in to your account or sign up in order to add this asset to your watchlist. document.write('
'); "Hi, I'm Jeff Brown… I'm about to get in this Tesla and drive up to a location just a few miles from here to show you Elon Musk's next big project… Looking for new stock ideas? Want to see which stocks are moving? Average Price Target. The price target was set to $17.00 → $5.00. Just click the link
Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Copyright © 2021. The lighter blue line represents the stock's consensus price target. Analysts have given the company’s stock an average 52-week price target of $8, forecast … As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. Get daily stock ideas top-performing Wall Street analysts. Coty Stock Providing Pullback Opportunities, America’s Car-Mart (NASDAQ:CRMT) Sets New High As Business Accelerates, 6 Hot Cannabis Stocks For Penny Stock Investors, 7 Great Dividend Stocks to Buy For a Comfortable Retirement, 7 Penny Stocks That Don’t Care About Robinhood, 7 Hotel Stocks Just Waiting For the Vaccine, 7 Stocks to Watch When Student Debt Forgiveness Gets Passed, 7 Healthcare Stocks Delivering Innovation in 2021, 7 Lithium Stocks That Will Power the Electric Vehicle Boom, 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell, Man Gets Into a Tesla… What Happens Next Will Shock Everyone (Video), "Hi, I'm Jeff Brown… I'm about to get in this Tesla and drive up to a location just a few miles from here to show you Elon Musk's next big project…, Receive Analysts' Upgrades and Downgrades Daily. 9 Wall Street analysts have issued ratings and price targets for Ovid Therapeutics in the last 12 months. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Identify stocks that meet your criteria using seven unique stock screeners. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Ovid Therapeutics Inc. (NASDAQ:OVID)’s beta value is holding at 1.86, while the average true range (ATR) indicator is currently reading 0.16. To see all exchange delays and terms of use please see disclaimer. Last 30 Days Make investment decisions regarding OVID using the data that counts. Most Recent Rating Royal Bank of Canada is very positive to OVID and gave it a "Outperform" rating on December 02, 2020. Ratings...FREE! appreciate its future potential. OVID updated stock price target summary. Ovid Therapeutics Inc's variance in analysts' estimates is lower than 14.53% of stocks … The average analyst price target of OVID is greater than 11.94% of all US stocks. Price target in 14 days: 4.513 USD. The best long-term & short-term Ovid Therapeutics share price prognosis for 2021, 2022, 2023, 2024, 2025, … MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Finally, JMP Securities lowered Ovid … There are currently 3 hold ratings and 6 buy ratings for the stock, resulting in a consensus rating of "Buy.". View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Shares of Ovid Therapeutics were up by 29.1%, despite the company not reporting any news. Their average twelve-month price target is $12.57, predicting that the stock has a possible upside of 262.29%. OVID - Ovid Therapeutics Inc Stock quote - CNNMoney.com Markets Amount of Analyst Coverage Ovid Therapeutics has been the … In the Pharmaceutical Products industry, ZYNE, OCUL and FULC are the three stocks most similar to Ovid Therapeutics Inc regarding the price target and analyst recommendation information presented here. Get short term trading ideas from the MarketBeat Idea Engine. Login The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock. The market is probably reacting to Ovid getting a buy rating from an analyst. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Find real-time OVID - Ovid Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. View which stocks are hot on social media with MarketBeat's trending stocks report. They're ALL securing the most bizarre… remote… ""offshore"" properties you can imagine. Ovid Therapeutics analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and …